Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus that their body's immune systems then see as foreign.
Bob Walker, chief medical officer at Novavax, says this method does a good job of mimicking the way the SARS-CoV-2 virus naturally infects the body, which could theoretically lead to some benefits in terms of the immune response.
Collection
[
|
...
]